Fourth, by using gene network and pathways analyses in SIRT1, IL6, G6PD, SNAP23, and ACLY genes, we revealed a potential role of several important biological processes and pathways mainly related to cellular and immunological processes, which may be engaged in changes of metabolic phenotypes of the GDM/SIRT1(↑) patients. This evidence concerns the gene IL6 and gestational diabetes.